Division Chief, Infectious Disease
Dr. Connick's research is focused on understanding the immunopathogenesis of HIV infection. She has been involved in clinical trials of a variety of immune therapies for HIV infection since 1994. She has also pursued laboratory-based investigations of HIV immunopathogenesis for the past 20 years particularly studies of acute HIV infection, virus tropism, immune reconstitution, cardiovascular disease, and HIV infection in women.
Dr. Connick's specific expertise in studies of HIV pathogenesis in lymphoid tissues, where the majority of HIV replication and CD4+ T cell destruction occurs. She currently has R01 bridge funding to investigate the mechanisms underlying HIV’s evasion of cytotoxic T cell responses in lymphoid tissues, and is co-PI of a R01 investigating the impact of exercise on endothelial dysfunction in HIV-infected individuals.